Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly kinase inhibitors for cancer treatment. Its structure, featuring a reactive chloromethyl group attached to the benzamide scaffold with a pyrazolyl moiety, enables further derivatization for selective binding to enzyme active sites in final drug molecules, making it valuable in drug design. Commonly employed in medicinal chemistry to modify bioavailability and enhance target specificity of active pharmaceutical ingredients. Also utilized in research to develop novel anti-inflammatory and antiviral agents due to its favorable reactivity and stability in coupling reactions.